[go: up one dir, main page]

Wagar et al., 2021 - Google Patents

Modeling human adaptive immune responses with tonsil organoids

Wagar et al., 2021

View PDF
Document ID
5612824396988405620
Author
Wagar L
Salahudeen A
Constantz C
Wendel B
Lyons M
Mallajosyula V
Jatt L
Adamska J
Blum L
Gupta N
Jackson K
Yang F
Röltgen K
Roskin K
Blaine K
Meister K
Ahmad I
Cortese M
Dora E
Tucker S
Sperling A
Jain A
Davies D
Felgner P
Hammer G
Kim P
Robinson W
Boyd S
Kuo C
Davis M
Publication year
Publication venue
Nature medicine

External Links

Snippet

Most of what we know about adaptive immunity has come from inbred mouse studies, using methods that are often difficult or impossible to confirm in humans. In addition, vaccine responses in mice are often poorly predictive of responses to those same vaccines in …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/26Flt-3 ligand (CD135L, flk-2 ligand)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay
    • G01N33/569Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Wagar et al. Modeling human adaptive immune responses with tonsil organoids
Heit et al. Vaccination establishes clonal relatives of germinal center T cells in the blood of humans
Waickman et al. Dissecting the heterogeneity of DENV vaccine-elicited cellular immunity using single-cell RNA sequencing and metabolic profiling
Arumugakani et al. Early emergence of CD19-negative human antibody-secreting cells at the plasmablast to plasma cell transition
Douam et al. Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses
Matsumoto et al. Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity
Cao et al. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization
Mount et al. Multiple dendritic cell populations activate CD4+ T cells after viral stimulation
Lu et al. Engineered murine HSCs reconstitute multi-lineage hematopoiesis and adaptive immunity
Budeus et al. Human cord blood B cells differ from the adult counterpart by conserved Ig repertoires and accelerated response dynamics
Morrocchi et al. Modeling human immune responses to vaccination in vitro
Sun et al. The kinase PDK1 is critical for promoting T follicular helper cell differentiation
Eaton et al. Bone marrow precursor cells from aged mice generate CD4 T cells that function well in primary and memory responses
CN114230658A (en) Novel coronavirus-specific T cell receptor and uses thereof
Deng et al. Cytokine diversity in the Th1-dominated human anti-influenza response caused by variable cytokine expression by Th1 cells, and a minor population of uncommitted IL-2+ IFNγ-Thpp cells
Choi et al. Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection
Sharma et al. The lipid globotriaosylceramide promotes germinal center B cell responses and antiviral immunity
Barroso et al. Molecular dissection of the antibody response: opportunities and needs for application in cattle
Feng et al. Pathogen-associated T follicular helper cell plasticity is critical in anti-viral immunity
Wang et al. A comprehensive analysis of the T and B lymphocytes repertoire shaped by HIV vaccines
Chai et al. A high-throughput single cell-based antibody discovery approach against the full-length SARS-CoV-2 spike protein suggests a lack of neutralizing antibodies targeting the highly conserved S2 domain
US20230235284A1 (en) Systems and methods to model adaptive immune responses
Paciello et al. B cell maturation restored ancestral germlines to control Omicron BA. 2.86
US20250066729A1 (en) Systems and Methods Incorporating Modified T-Cells
Fujitani et al. Longitudinal analysis of immune responses to SARS-CoV-2 recombinant vaccine S-268019-b in phase 1/2 prime-boost study